|
|
Volumn 100, Issue 4, 2007, Pages 166-169
|
|
Paying for cancer care - A new dilemma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
BORTEZOMIB;
CETUXIMAB;
ERLOTINIB;
IMATINIB;
LAPATINIB;
MONOCLONAL ANTIBODY;
PANITUMUMAB;
RANIBIZUMAB;
RITUXIMAB;
SORAFENIB;
SUNITINIB;
TRASTUZUMAB;
BREAST CANCER;
CANCER;
CANCER DIAGNOSIS;
CANCER PATIENT;
CANCER RADIOTHERAPY;
COLORECTAL CANCER;
DIAGNOSTIC IMAGING;
DRUG COST;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HUMAN;
LUNG CANCER;
NATIONAL HEALTH SERVICE;
OVERALL SURVIVAL;
PATIENT CARE;
PRACTICE GUIDELINE;
PRIMARY HEALTH CARE;
REVIEW;
|
|
EID: 34247872787
PISSN: 01410768
EISSN: None
Source Type: Journal
DOI: 10.1258/jrsm.100.4.166 Document Type: Review |
|
Times cited : (13)
|
|
References (5)
|
